Big Pharma Split Corp Class A (PRM)

Toronto


Symbol		Exchange		Currency
PRM	·	Toronto	·	CAD	Real-time
PRM_pa	·	Toronto	·	CAD	Real-time

Currency in CAD

13.41

+0.12(+0.90%)

Closed·16:01:29

Fair Value

Unlock Value

Day's Range

13.28

13.41

52 wk Range

10.71

15.50

PRM Financial Summary

A brief financial summary of Big Pharma Split Corp Class A as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Key Ratios

P/E Ratio3.7

Price/Book1.03

Debt / Equity72.09%

Return on Equity27.55%

Dividend Yield9.02%

EBITDA0.00

Fair ValueUnlock

Fair Value UpsideUnlock

Statements Highlights

Period Ending:

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Income Statement

Total Revenues

aa.aa

6.65

0.32

3.01

5.11

Gross Profit

aa.aa

6.65

0.32

3.01

5.11

Operating Income

aa.aa

5.76

-0.36

2.35

4.34

Net Income

aa.aa

2.39

-0.65

-0.54

4.4

Balance Sheet

Total Assets

aa.aa

39.1

26.53

26.3

31.84

Total Current Liabilities

aa.aa

19.37

10.68

12.62

13.57

Total Equity

aa.aa

19.73

15.85

13.68

18.27

Cash Flow

Levered Free Cash Flow

aa.aa

-1.39

4.09

2.48

1.16

Cash from Operations

aa.aa

1.13

11.86

1.71

-0.89

Cash from Investing

aa.aa

Cash from Financing

aa.aa

-1.74

-12.47

-0.88

1.2

Net Change in Cash

aa.aa

-0.61

-0.62

0.83

0.32

* In Millions of CAD (except for per share items)

Dividends

Payout Ratio

Payout ratio (TTM)

Earnings retained

EPS 3.59%

Dividend Yield

9.02%

Industry Median 6.12%

Annualized payout

1.24

Paid monthly

5-Years Growth

+31.95%

Growth Streak

Unlock

Earnings

Latest Release

Mar 30, 2026

EPS / Forecast

3.85 / --

Revenue / Forecast

6.01M / --

EPS Revisions

Unlock

Last 90 days

FAQ

What were Big Pharma Split A's earnings for the latest quarter?

The Big Pharma Split A EPS (TTM) is 3.59. Big Pharma Split A reported sales of 6.01, net income of 4.89, and EPS of 3.85 for the latest quarter.

What was Big Pharma Split A's net income for the latest quarter?

Big Pharma Split A's net income for the latest quarter was 4.89.

How did Big Pharma Split A's performance compare year-over-year in the latest quarter?

The company's revenue moved from -0.90 million CAD in the previous quarter to 6.01 million CAD in the latest quarter, and net income moved from -0.49 million CAD to 4.89 million CAD compared to the previous quarter.

What is Big Pharma Split A's net profit margin on a TTM basis?

Big Pharma Split A's trailing twelve months (TTM) net profit margin is 86.11%%.

How does Big Pharma Split A's debt to equity ratio compare to industry standards?

Big Pharma Split A's total debt-to-equity ratio is 72.09%.

What is Big Pharma Split A's return on investment on a TTM basis?

Big Pharma Split A's trailing twelve months (TTM) return on investment (ROI) is 27.55%.

What is Big Pharma Split A's gross margin on a TTM basis?

Big Pharma Split A's trailing twelve months (TTM) gross margin is 100.00%%.

What was Big Pharma Split A's revenue per share for the latest quarter?

Big Pharma Split A's revenue per share for the latest quarter was 4.20.

S&P/TSX

33,964.33

+645.94

+1.94%

S&P/TSX 60

1,982.72

+38.92

+2.00%

US 30

49,795.00

+143.1

+0.29%

US 500

7,233.80

+24.8

+0.34%

S&P 500 VIX

16.89

-1.92

-10.21%

DAX

24,292.38

+337.82

+1.41%

Dollar Index

97.997

+0.078

+0.08%

Market Movers

Name	Last	Chg. %	Vol.
Enbridge	75.34	+3.19%	9.52M
TC Energy	91.08	+4.02%	9.32M
Toronto Dominion Bank	146.33	+2.38%	6.34M
Bank of Nova Scotia	105.68	+1.99%	5.92M
Bank of Montreal	206.84	+1.90%	5.15M
RBC	244.31	+1.80%	3.16M
Canadian Imperial Bank	151.57	+2.72%	2.90M

Name	Last	Chg. %	Vol.
PeakBirch Logic	0.030	+500.00%	1.32K
Irwin Naturals	0.30	+150.00%	3.24K
Thermopylae Capital	0.09	+142.86%	6.00K
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
ePlay Digital	0.010	+100.00%	7.00K
Big Tree Carbon	0.0100	+100.00%	11.52K
Spod Lithium	0.01	+100.00%	2.64K

Name	Last	Chg. %	Vol.
Vertiqal Studios	0.01	-100.00%	31.41K
Vertiqal Studios	0.01	-100.00%	31.41K
Nirvana Life Sciences	0.01	-75.00%	8.00K
BYT Holdings	0.01	-75.00%	343.00K
Resource Centrix Holdings	1.50	-60.00%	600.00
Patriot Gold	0.07	-51.85%	1.00K
Patriot Gold	0.07	-51.85%	1.00K

Trending Stocks

Name	Last	Chg. %	Vol.
Air Canada	18.65	+3.55%	3.75M
Bombardier Inc	288.640	+20.61%	1.10M
Whitecap Resources	16.03	+0.06%	9.86M
Cenovus Energy Inc	39.74	+0.94%	5.87M
Celestica Inc.	557.68	+8.25%	592.83K

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaa	5.31	+66.23%	8.83
Aaa A Aaaaaa Aa	88.91	+65.72%	147.34
Aaaaaa Aaaaa	6.14	+50.07%	9.21
Aaaaa A Aaaaaaa Aa	2,473.89	+46.73%	3,629.94
Aaaaaaaaaaaaaaaaaaaa	11.32	+45.35%	16.45
Aaaaaaa	114.45	+40.90%	161.26
Aaa Aaaaaaaaa	23.35	+40.86%	32.89

Name	Last	Upside	Fair Value
Aaaaa	5.31	+66.23%	8.83
Aaa A Aaaaaa Aa	88.91	+65.72%	147.34
Aaaaaa Aaaaa	6.14	+50.07%	9.21
Aaaaa A Aaaaaaa Aa	2,473.89	+46.73%	3,629.94
Aaaaaaaaaaaaaaaaaaaa	11.32	+45.35%	16.45
Aaaaaaa	114.45	+40.90%	161.26
Aaa Aaaaaaaaa	23.35	+40.86%	32.89

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Big Pharma Split Corp Class A (PRM)

PRM Financial Summary

Key Ratios

Statements Highlights

Dividends

Earnings

FAQ

What were Big Pharma Split A's earnings for the latest quarter?

What was Big Pharma Split A's net income for the latest quarter?

How did Big Pharma Split A's performance compare year-over-year in the latest quarter?

What is Big Pharma Split A's net profit margin on a TTM basis?

How does Big Pharma Split A's debt to equity ratio compare to industry standards?

What is Big Pharma Split A's return on investment on a TTM basis?

What is Big Pharma Split A's gross margin on a TTM basis?

What was Big Pharma Split A's revenue per share for the latest quarter?

Trending Stocks